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Background: Coronary artery disease (CAD) is a major cause of morbidity and mortality in renal transplant patients. While SPECT imaging is 
prognostic of cardiac events in pre-renal transplant evaluation, there is paucity of data on its utility in post-renal transplant patients.
Methods: We retrospectively analyzed asymptomatic post-renal transplant patients who have undergone T-99m SPECT imaging for routine 
screening for ischemia. Data on the patient characteristics, SPECT findings, outcomes including stroke, peripheral artery disease and major adverse 
coronary outcomes (MACE) were reviewed.
Results: 138 renal transplant patients (age 48.8 ± 9 years) underwent 290 SPECT imaging scans between January 2003 to December 2006. 
Chronic glomerulonephritis was the main cause of renal failure and the median duration of transplant was 40 months. Eighteen (13.0%) had prior 
CAD, 46(33.4%) had diabetes and 109 (79.0%) had hypertension. The median follow-up duration was 50 months. Ischemia was detected in 17 
(12.3%) patients. Patients with abnormal scans tended to have poorer ejection fraction (58% vs 65% p<0.001) and longer post-transplant duration 
(105 vs 54 months p=0.049). 20 events occurred in 15 (10.8%) patients during follow up. The earliest MACE occurred 3 years after transplant. Five 
(3.9%) developed MACE, 5 (3.9%) developed strokes and 9 (6.5%) died of non-cardiac related causes. The sensitivity, specificity, positive predictive 
value and negative predictive value of abnormal SPECT scan in predicting MACE were 60%, 88%, 14% and 99% respectively. Univariate correlates 
predicting MACE include abnormal SPECT scan [OR = 9.0 (1.4-57.5)] and a prior history of CAD [OR = 11.8 (1.8-76.4)].
Conclusions: T-99m SPECT imaging predicts MACE with high specificity in patients post renal transplant . However, the incidence of cardiac events 
in our cohort was low at 1% per year. This suggests that early (less than 3 years post transplant) non-selective screening for ischemia may not be 
cost-effective in this group. Further studies are warranted to identify a specific subset of renal transplant patients who are at greatest risk to benefit 
from screening.
